Johnson & Johnson Reports 2011 Q4 and Full-Year Results – Hispanic Business

Sales results in the U.S. were negatively impacted by generic competition for LEVAQUIN (levofloxacin), a treatment for bacterial infections, which was offset by the strong performance of recently launched products. The strong performance of recently …

Leave a Reply

Your email address will not be published.

*